Chandra Bhagat Pharma Quarterly Results for Trading Insights

CBPL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Quarterly Results

Chandra Bhagat Pharma Quarterly Results Key Highlights

  • Revenue of ₹92 Cr in March 2025 (+0.0% vs March 2025, -60.5% vs March 2024)
  • Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, -50.0% vs March 2024)
  • EBITDA of ₹4 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of -2.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.14 in March 2025 (+0.0% vs March 2025)

Chandra Bhagat Pharma Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 92 233 120 96 - -
Net Profit (₹ Cr) 0 1 2 1 1 - -
EBITDA (₹ Cr) 0 4 4 4 4 - -
EPS (₹) 0.00 1.14 2.03 1.20 1.06 - -
Operating Margin (%) 0.0% -2.0% -3.0% 3.0% 3.0% - -

Chandra Bhagat Pharma Share Price Trend Around Quarterly Results

Visualize Chandra Bhagat Pharma's 1-year price movement across quarterly results — ideal for logging trades in Chandra Bhagat Pharma share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 1.1%
EBITDA Margin 4.3%
Operating Margin -2.0%
ROE (Annual) 3.3%

Balance Sheet Highlights

Total Assets ₹102 Cr
Total Equity ₹30 Cr
Current Assets ₹98 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹-6 Cr
Investing Cash Flow ₹-1 Cr
Financing Cash Flow ₹2 Cr
Net Cash Flow ₹-5 Cr

Sector Competitors - Quarterly Performance Comparison

Comparing Chandra Bhagat Pharma quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹438,094.57 Cr 1825.9 14,875 3,125 +10.8% - 21.0% 140.5
Divis Laboratories
Sept 2025
₹167,616.86 Cr 6352.5 2,860 689 +7.1% - 24.1% 244.6
Torrent Pharmaceuti…
Sept 2025
₹148,025.88 Cr 4431.2 3,219 591 +11.3% - 18.4% 252.6
Dr Reddys Laborator…
Sept 2025
₹110,630.25 Cr 1325.5 9,135 1,337 +1.1% - 14.6% 81.9
Cipla
Sept 2025
₹107,029.80 Cr 1329.5 7,716 1,353 +12.0% - 17.5% 79.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores